India
· Delayed Price · Currency is INR Alembic Pharmaceuticals Statistics
Total Valuation
BOM:533573 has a market cap or net worth of INR 188.10 billion. The enterprise value is 199.83 billion.
| Market Cap | 188.10B |
| Enterprise Value | 199.83B |
Important Dates
The last earnings date was Monday, August 4, 2025.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Jul 29, 2025 |
Share Statistics
| Current Share Class | 196.56M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 57.33M |
Valuation Ratios
The trailing PE ratio is 31.19 and the forward PE ratio is 24.95.
| PE Ratio | 31.19 |
| Forward PE | 24.95 |
| PS Ratio | 2.76 |
| PB Ratio | 3.62 |
| P/TBV Ratio | 3.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 33.13 |
| EV / Sales | 2.93 |
| EV / EBITDA | 19.04 |
| EV / EBIT | 25.96 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 1.20 |
| Debt / FCF | n/a |
| Interest Coverage | 8.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.17% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.12M |
| Profits Per Employee | 363,943 |
| Employee Count | 16,571 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:533573 has paid 1.39 billion in taxes.
| Income Tax | 1.39B |
| Effective Tax Rate | 18.80% |
Stock Price Statistics
The stock price has decreased by -11.75% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.75% |
| 50-Day Moving Average | 985.11 |
| 200-Day Moving Average | 963.05 |
| Relative Strength Index (RSI) | 44.46 |
| Average Volume (20 Days) | 6,622 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533573 had revenue of INR 68.21 billion and earned 6.03 billion in profits. Earnings per share was 30.69.
| Revenue | 68.21B |
| Gross Profit | 49.27B |
| Operating Income | 7.70B |
| Pretax Income | 7.40B |
| Net Income | 6.03B |
| EBITDA | 10.30B |
| EBIT | 7.70B |
| Earnings Per Share (EPS) | 30.69 |
Balance Sheet
The company has 834.80 million in cash and 12.58 billion in debt, giving a net cash position of -11.74 billion.
| Cash & Cash Equivalents | 834.80M |
| Total Debt | 12.58B |
| Net Cash | -11.74B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 51.90B |
| Book Value Per Share | 264.09 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 72.23%, with operating and profit margins of 11.28% and 8.84%.
| Gross Margin | 72.23% |
| Operating Margin | 11.28% |
| Pretax Margin | 10.85% |
| Profit Margin | 8.84% |
| EBITDA Margin | 15.11% |
| EBIT Margin | 11.28% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.17%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.10% |
| Shareholder Yield | 1.27% |
| Earnings Yield | 3.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |